Labels:text | screenshot | black | black and white | font OCR: If the By reducing IGF2 production by remo tumour (if this is surgically possible) o on by temporarily increasing IGF-BP3 produ ion (Fig. exogenous growth hormone administr be 20.22), the hypoglycaemia of NICTH m sible or to relieved sufficiently to make surgery p e of the improve the quality of the remaining patient